• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.北日德兰郡糖尿病视网膜病变研究(NCDRS)2. 非眼科参数与临床显著性黄斑水肿。
Br J Ophthalmol. 2007 Dec;91(12):1593-5. doi: 10.1136/bjo.2006.111872. Epub 2007 Jan 3.
2
The North Jutland County Diabetic Retinopathy Study (NCDRS).北日德兰糖尿病视网膜病变研究(NCDRS)。
Acta Ophthalmol. 2010 Jun;88(4):443-8. doi: 10.1111/j.1755-3768.2009.01555.x. Epub 2009 Aug 14.
3
Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project.偏远原住民初级医疗人群中的糖尿病视网膜病变:远程医疗眼科及相关医疗服务网络项目中的澳大利亚中部糖尿病视网膜病变筛查研究
Diabet Med. 2018 May;35(5):630-639. doi: 10.1111/dme.13596. Epub 2018 Feb 27.
4
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study.意大利老年白内障手术患者中糖尿病及糖尿病性黄斑水肿的患病率:糖尿病与白内障研究
Eur J Ophthalmol. 2020 Mar;30(2):315-320. doi: 10.1177/1120672119830578. Epub 2019 Mar 11.
5
Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R).老年人糖尿病与非糖尿病视网膜病变:年龄、基因/环境易感性-雷克雅未克研究(AGES-R)。
Diabetologia. 2012 Mar;55(3):671-80. doi: 10.1007/s00125-011-2395-y. Epub 2011 Dec 2.
6
Higher age at onset of type 1 diabetes increases risk of macular oedema.1 型糖尿病发病年龄越大,黄斑水肿的风险越高。
Acta Ophthalmol. 2013 Dec;91(8):709-15. doi: 10.1111/j.1755-3768.2012.02522.x. Epub 2012 Sep 13.
7
Is the pulse rate useful in assessing risk of diabetic retinopathy and macular oedema? The Wisconsin Epidemiological Study of Diabetic Retinopathy.脉搏率在评估糖尿病视网膜病变和黄斑水肿风险方面有用吗?威斯康星糖尿病视网膜病变流行病学研究。
Br J Ophthalmol. 2001 Aug;85(8):925-7. doi: 10.1136/bjo.85.8.925.
8
Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes.妊娠导致的 1 型糖尿病女性视力威胁性糖尿病视网膜病变。
Diabet Med. 2010 Apr;27(4):431-5. doi: 10.1111/j.1464-5491.2010.02958.x.
9
Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema.系统性风险因素对增殖性糖尿病性视网膜病变和临床显著黄斑水肿的发展有不同的影响。
Diabetologia. 2020 Nov;63(11):2462-2470. doi: 10.1007/s00125-020-05234-0. Epub 2020 Jul 21.
10
Diabetic macular oedema: clinical risk factors and emerging genetic influences.糖尿病性黄斑水肿:临床危险因素及新出现的遗传影响
Clin Exp Optom. 2017 Nov;100(6):569-576. doi: 10.1111/cxo.12552. Epub 2017 May 26.

引用本文的文献

1
Association of urinary albumin excretion with central foveal thickness and intravitreal conbercept treatment frequency in patients with diabetic macular edema.糖尿病性黄斑水肿患者尿白蛋白排泄与中心凹厚度及玻璃体内康柏西普治疗频率的相关性
Int J Ophthalmol. 2019 Oct 18;12(10):1598-1604. doi: 10.18240/ijo.2019.10.12. eCollection 2019.
2
Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney).基于人群的糖尿病黄斑水肿研究概况:利物浦眼与糖尿病研究(悉尼)。
BMJ Open. 2019 Jan 24;9(1):e021884. doi: 10.1136/bmjopen-2018-021884.
3
Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.2型糖尿病视网膜病变和糖尿病性黄斑水肿的危险因素——来自德国/奥地利糖尿病患者数据收集与分析系统(DPV)数据库的结果
PLoS One. 2015 Jul 15;10(7):e0132492. doi: 10.1371/journal.pone.0132492. eCollection 2015.
4
Optimal treatment of diabetic retinopathy.糖尿病性视网膜病变的最佳治疗方法。
Ther Adv Endocrinol Metab. 2013 Apr;4(2):61-71. doi: 10.1177/2042018813477886.
5
Current treatments in diabetic macular oedema: systematic review and meta-analysis.糖尿病性黄斑水肿的当前治疗方法:系统评价和荟萃分析。
BMJ Open. 2013 Mar 1;3(3):e002269. doi: 10.1136/bmjopen-2012-002269.
6
Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes.2型糖尿病多民族人群中具有临床意义的黄斑水肿的危险因素。
Int J Ophthalmol. 2012;5(4):499-504. doi: 10.3980/j.issn.2222-3959.2012.04.18. Epub 2012 Aug 18.
7
Ranibizumab: in diabetic macular oedema.雷珠单抗:用于糖尿病性黄斑水肿。
Drugs. 2012 Mar 5;72(4):509-23. doi: 10.2165/11208410-000000000-00000.
8
Current approaches to the management of diabetic retinopathy and diabetic macular oedema.目前糖尿病视网膜病变和糖尿病黄斑水肿的管理方法。
Drugs. 2010 Nov 12;70(16):2171-200. doi: 10.2165/11538130-000000000-00000.

本文引用的文献

1
The North Jutland County Diabetic Retinopathy Study: population characteristics.北日德兰郡糖尿病视网膜病变研究:人群特征
Br J Ophthalmol. 2006 Nov;90(11):1404-9. doi: 10.1136/bjo.2006.093393. Epub 2006 Jul 6.
2
Epidemiology of diabetic retinopathy and macular oedema: a systematic review.糖尿病视网膜病变和黄斑水肿的流行病学:一项系统综述
Eye (Lond). 2004 Oct;18(10):963-83. doi: 10.1038/sj.eye.6701476.
3
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.
4
The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.强化糖尿病治疗对胰岛素依赖型糖尿病患者糖尿病视网膜病变进展的影响。糖尿病控制与并发症试验。
Arch Ophthalmol. 1995 Jan;113(1):36-51. doi: 10.1001/archopht.1995.01100010038019.
5
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.威斯康星糖尿病视网膜病变流行病学研究。IV. 糖尿病性黄斑水肿。
Ophthalmology. 1984 Dec;91(12):1464-74. doi: 10.1016/s0161-6420(84)34102-1.
6
Ocular complications in insulin treated diabetes mellitus. An epidemiological study.胰岛素治疗的糖尿病的眼部并发症。一项流行病学研究。
Acta Ophthalmol Suppl (1985). 1985;172:1-77.
7
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.糖尿病性黄斑水肿的光凝治疗。糖尿病视网膜病变早期治疗研究报告第1号。糖尿病视网膜病变早期治疗研究研究组。
Arch Ophthalmol. 1985 Dec;103(12):1796-806.
8
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema.威斯康星糖尿病视网膜病变流行病学研究。XI. 黄斑水肿的发病率。
Ophthalmology. 1989 Oct;96(10):1501-10. doi: 10.1016/s0161-6420(89)32699-6.

北日德兰郡糖尿病视网膜病变研究(NCDRS)2. 非眼科参数与临床显著性黄斑水肿。

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.

作者信息

Knudsen L L, Lervang H-H, Lundbye-Christensen S, Gorst-Rasmussen A

机构信息

Department of Ophthalmology, Aarhus University Hospital, Aalborg Sygehus Syd, Hobrovej 18-22, DK-9100 Aalborg, Denmark.

出版信息

Br J Ophthalmol. 2007 Dec;91(12):1593-5. doi: 10.1136/bjo.2006.111872. Epub 2007 Jan 3.

DOI:10.1136/bjo.2006.111872
PMID:17202201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2095526/
Abstract

BACKGROUND

The influence of non-ophthalmic parameters on the prevalence of clinically significant macular oedema has not been unambiguously established. The present study was initiated with the aim of clarification.

METHODS

This cross-sectional study comprised 656 type 1 and 328 type 2 diabetic subjects undergoing retinopathy screening in the county of North Jutland. The association between the presence of clinically significant macular oedema and blood pressure, HbA1c, BMI, age, onset of diabetes, duration of diabetes, blood-pressure-reducing medication, lipid-lowering medication, neuropathy and urinary albumin excretion was explored using multiple logistic regression analysis.

RESULTS

We found no significant association between the presence of clinically significant macular oedema and any of the examined parameters in type 1 diabetic subjects. In type 2 diabetic subjects, the duration of diabetes, HbA1c, neuropathy and increased urinary albumin excretion was significantly associated with the presence of clinically significant macular oedema.

CONCLUSIONS

The risk factors for clinically significant macular oedema differ in type 1 and type 2 diabetic subjects and can account only in part for this manifestation.

摘要

背景

非眼科参数对临床上显著黄斑水肿患病率的影响尚未明确确立。本研究旨在对此进行阐明。

方法

这项横断面研究纳入了在北日德兰郡接受视网膜病变筛查的656例1型糖尿病患者和328例2型糖尿病患者。采用多因素逻辑回归分析探讨临床上显著黄斑水肿的存在与血压、糖化血红蛋白(HbA1c)、体重指数(BMI)、年龄、糖尿病发病时间、糖尿病病程、降压药物、降脂药物、神经病变及尿白蛋白排泄之间的关联。

结果

我们发现1型糖尿病患者中临床上显著黄斑水肿的存在与任何所检查参数之间均无显著关联。在2型糖尿病患者中,糖尿病病程、HbA1c、神经病变及尿白蛋白排泄增加与临床上显著黄斑水肿的存在显著相关。

结论

1型和2型糖尿病患者临床上显著黄斑水肿的危险因素不同,且只能部分解释这一表现。